What is the share price of Dipna Pharmachem Ltd (DPL) today?
The share price of DPL as on 7th March 2025 is ₹13.26. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dipna Pharmachem Ltd (DPL) share?
The past returns of Dipna Pharmachem Ltd (DPL) share are- Past 1 week: -2.85%
- Past 1 month: -22.52%
- Past 3 months: 64.52%
- Past 6 months: 62.10%
- Past 1 year: 15.30%
- Past 3 years: N/A%
- Past 5 years: -51.68%
What are the peers or stocks similar to Dipna Pharmachem Ltd (DPL)?
The peers or stocks similar to Dipna Pharmachem Ltd (DPL) include:What is the market cap of Dipna Pharmachem Ltd (DPL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dipna Pharmachem Ltd (DPL) is ₹31.88 Cr as of 7th March 2025.What is the 52 week high and low of Dipna Pharmachem Ltd (DPL) share?
The 52-week high of Dipna Pharmachem Ltd (DPL) is ₹16.55 and the 52-week low is ₹6.40.What is the PE and PB ratio of Dipna Pharmachem Ltd (DPL) stock?
The P/E (price-to-earnings) ratio of Dipna Pharmachem Ltd (DPL) is 29.52. The P/B (price-to-book) ratio is 0.85.Which sector does Dipna Pharmachem Ltd (DPL) belong to?
Dipna Pharmachem Ltd (DPL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Dipna Pharmachem Ltd (DPL) shares?
You can directly buy Dipna Pharmachem Ltd (DPL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dipna Pharmachem Ltd
DPLDipna Pharmachem Ltd
DPL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹31 cr, stock is ranked 3,815
High RiskStock is 4.60x as volatile as Nifty
13.264.99% (+0.63)
13.264.99% (+0.63)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 0.85 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.25 | 6.02 | 0.55% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Dipna Pharmachem Limited trades and imports pharmaceutical raw materials and active ingredients, assisting in contract manufacturing compliance.
Peers
Compare with peersSUNPHARMA
PE Ratio
40.32
1Y Return
0.22%
Buy Reco %
85.29
CIPLA
PE Ratio
28.58
1Y Return
1.67%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
62.81
1Y Return
15.35%
Buy Reco %
68.00
MANKIND
PE Ratio
49.95
1Y Return
7.51%
Buy Reco %
80.00
DRREDDY
PE Ratio
16.93
1Y Return
10.40%
Buy Reco %
45.16
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16.57 | 20.19 | 30.55 | 31.02 | 72.77 | 99.94 | 164.34 | — | ||||||||
Raw Materials | 17.08 | 17.52 | 31.16 | 31.22 | 67.67 | 108.13 | 176.35 | — | ||||||||
| Power & Fuel Cost | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |||||||||
| Employee Cost | 0.00 | 0.00 | 0.38 | 0.41 | 0.00 | 0.00 | 0.00 | |||||||||
| Selling & Administrative Expenses | 0.70 | 0.63 | 0.61 | 0.54 | 1.66 | 1.92 | 2.77 | |||||||||
| Operating & Other expenses | -1.62 | 1.53 | -2.07 | -1.57 | 1.25 | -12.48 | -18.24 | |||||||||
EBITDA | 0.40 | 0.50 | 0.47 | 0.42 | 2.19 | 2.37 | 3.45 | — | ||||||||
| Depreciation/Amortization | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | — | ||||||||
| PBIT | 0.40 | 0.49 | 0.46 | 0.41 | 2.18 | 2.36 | 3.43 | — | ||||||||
| Interest & Other Items | 0.33 | 0.43 | 0.39 | 0.35 | 0.61 | 0.97 | 2.01 | — | ||||||||
| PBT | 0.07 | 0.06 | 0.07 | 0.06 | 1.57 | 1.39 | 1.42 | — | ||||||||
| Taxes & Other Items | 0.01 | 0.02 | 0.00 | 0.03 | 0.41 | 0.47 | 0.34 | — | ||||||||
| Net Income | 0.06 | 0.04 | 0.07 | 0.03 | 1.16 | 0.92 | 1.08 | — | ||||||||
| EPS | 2.93 | 1.96 | 3.42 | 1.47 | 56.74 | 1.25 | 0.56 | — | ||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dipna Pharmachem Ltd | 29.52 | 0.85 | — |
| Sun Pharmaceutical Industries Ltd | 40.32 | 5.75 | 0.84% |
| Cipla Ltd | 28.58 | 4.39 | 0.89% |
| Torrent Pharmaceuticals Ltd | 62.81 | 15.17 | 0.91% |
Price Comparison
Compare DPL with any stock or ETFCompare DPL with any stock or ETF
DPL
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
DPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Corporate
Dipna Pharmachem to hold board meeting
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 12 March 2025.Powered by Capital Market - Live
1 hour agoCapital Market - Live
Corporate
Dipna Pharmachem announces board meeting date
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 24 February 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Dipna Pharmachem to convene board meeting
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Dipna Pharmachem announces board meeting date
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 29 July 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 52.1%, vs industry avg of 9.04%
Increasing Market Share
Over the last 5 years, market share increased from 0.01% to 0.04%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 93.32%, vs industry avg of 15.27%